A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors
Tona M. Gilmer(GlaxoSmithKline (United States)), Michael B. Kastan(Duke University), Yaode Wang(Beijing Solar Energy Research Institute), Amy E. Stewart(Duke University), Kris C. Wood(Duke University), Katherine Deland(Duke University), David G. Kirsch(Princess Margaret Cancer Centre), Kathleen A. Ashcraft(Duke University), Chun-Hsiang Lai(Duke University), Jianmin Fu(Beijing Solar Energy Research Institute), Kexiao Guo(Duke University)
Cited by 30
Related Papers
Restoration of p53 function leads to tumour regression in vivo
|Nature|2007|1.8k
The complexity of p53 modulation: emerging patterns from divergent signals
|Genes & Development|1998|1.3k
DNA damage induces phosphorylation of the amino terminus of p53
|Genes & Development|1997|824
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
|Journal of Biological Chemistry|1999|810
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717